Epista Life Science Inc. - open for business

King of Prussia, PA - March 12, 2024:

Epista Life Science, a Life Science-focused digital services and consultancy firm, announced today their latest expansion, a new subsidiary in Pennsylvania, US.

The US is the largest pharmaceutical market in the world and a pivotal player in the global healthcare space. Epista Life Science’s presence in the United States enables the company to reach a significantly broader audience while continuing to pioneer and make an impact with their existing portfolio (Clinical, Regulatory, Quality, ERP and Veeva expertise) and new Business areas within Commercial Services and Manufacturing Operations.

Epista provides a Services Portfolio that enables Life Science companies around the globe to embrace digitalization across the Life Sciences value chain. Epista’s Business Area focus and agile collaboration model has matured over decades and the company’s portfolio  spans a variety of solutions within the Life Science industry.

“Our expansion into the United States, marks yet another important moment for our company as we aim to expand our international footprint. This strategic move aligns with our commitment to growth, aligning our Life Science focus with the largest pharmaceutical market in the world. This groundbreaking expansion will support Epista’s continuing vision,” states Flemming Kjoeller, SVP and Chief Growth Officer in the company.

Klavs Esbjerg, CEO, added, “´I founded the company with a long-term goal to build a global services platform for Life Science, so expanding into the United States not only gives us an important foothold in a strong and growing market, but also brings us one step closer to completing our vision and helping Life Science companies bring their health care innovations to patients in need.”

This exciting expansion is possible due to the appointment of Toni Lakin-Ritter as Managing Director of the US entity. With +15 years of experience working for companies such as CGI, Paragon, Phlexglobal and NNIT, Toni is committed to fostering commercial and delivery excellence and developing the most talented professionals. She noted, “I am happy to join Epista and use my strong commercial background and extensive Life Science experience to empower companies of all sizes to embrace digital transformation and accelerate their path to delivering innovative medicines to patients. Together, we will empower our customers to harness the power of digital technologies, optimize their operations, enhance quality, and drive sustainable growth."

‍

______________________________

For more information please contact:

Flemming Kjoeller, SVP & Chief Growth Officer – email: FLK@epista.com

‍

About Epista

Epista Life Science (Epista) is an IT service and consulting company with 150 employees that assists life science companies worldwide with digitalization, validation, and quality assurance. They are headquartered in Denmark and have subsidiaries in Sweden, Germany, and Switzerland. The company works at the intersection of business and compliance to anticipate the impacts that changing technology and regulatory requirements will have on the industry. By implementing technologies and pioneering methodologies, Epista helps their clients adapt while also increasing their performance. In this way, they help the industry drive the innovations that improve health care around the world.

‍

‍